Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
51,855,668
-
Share change
-
+943,706
-
Total reported value
-
$7,738,313,733
-
Put/Call ratio
-
97%
-
Price per share
-
$149.28
-
Number of holders
-
436
-
Value change
-
+$162,667,912
-
Number of buys
-
232
-
Number of sells
-
163
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2019
As of 31 Dec 2019,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
436 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,855,668 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, AQR CAPITAL MANAGEMENT LLC, JPMORGAN CHASE & CO, LSV ASSET MANAGEMENT, Nuveen Asset Management, LLC, STATE STREET CORP, FMR LLC, and Boston Partners.
This page lists
437
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.